Literature DB >> 12403401

Epidemiology of end-stage renal disease and current status of hemodialysis in Yugoslavia.

L Djukanović1, M Radović, J Baković, I Budosan, D Bukvić, A Cveticanin, S Davinić, B Dragoljić, V Djordjević, S Djurić, B Haviza-Lilić, M Ilić, B Janos, R Jelacić, S Jelić, N Kostić, M Mandić, V Ostrić, S Pljesa, M Radisić, M Radojević, N Rakić, V Rangelov, M Ratković, M Stojanović, R Stojanović, D Tintor, V Vasić.   

Abstract

Maintenance hemodialysis (HD) in Yugoslavia started in the sixties and followed the dialysis trends in the Western Europe. However, in the last decade the development of renal replacement therapy (RRT) slowed down. In this report the epidemiology of ESRD from 1997-1999 and the survey of the status of HD treatment in Yugoslavia in 1999 are presented. Epidemiological data are obtained by the annual center questionnaires (response rate: 92.6 -94.2%). The survey of HD status is based on a specific questionnaire and covered 2108 patients (65%). At the end of 1999 there were 56 RRT centers in Yugoslavia treating 3939 patients: 3232 (82%) patients by HD, 248 (6.3%) by peritoneal dialysis, and 459 (11.7%) living with transplanted kidney. In a three year period, incidence of ESRD ranged from 108-128 pmp, point prevalence from 435-463 pmp and mortality rate from 20.7-17.9. Numerous refugee patients were treated over the last 10 years. Main causes of ESRD were glomerulonephritis (30%); Balkan nephropathy represented 11% and diabetic nephropathy 7% of all primary renal diseases. Cardiovascular and cerebrovascular diseases were the most common causes of death of RRT patients. Most centers are overcrowded and HD machines are worn out. Mean Kt/V was 1.19+/-0.08, mean URR% 58.8+/-7.4. The shortage of drugs prevented adequate management: 83% of HD patients had hemoglobin level less than 100 g/L but only 10.3 -17.8% were treated with rHuEpo; 64.5% of patients had phosphate levels higher than 1.7 mmol/L but only 33.5% used phosphate binders; 47% of patients had hypertension despite the antihypertensive therapy. The prevalence of hepatitis B remained unchanged (about 14%) in HD population during the last three years, but the prevalence of anti-HCV positive patients decreased (31-23%). In conclusion, there is a well developed dialysis service in Yugoslavia but insufficient conditions for adequate treatment.

Entities:  

Mesh:

Year:  2002        PMID: 12403401     DOI: 10.1177/039139880202500907

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  4 in total

Review 1.  [Interstitial nephritis].

Authors:  J Halbritter; C Mayer; F M Rasche; K Amann; T H Lindner
Journal:  Internist (Berl)       Date:  2009-09       Impact factor: 0.743

Review 2.  Balkan endemic nephropathy-current status and future perspectives.

Authors:  Nikola M Pavlović
Journal:  Clin Kidney J       Date:  2013-06

3.  Macrophage interferon regulatory factor 4 deletion ameliorates aristolochic acid nephropathy via reduced migration and increased apoptosis.

Authors:  Kensuke Sasaki; Andrew S Terker; Jiaqi Tang; Shirong Cao; Juan Pablo Arroyo; Aolei Niu; Suwan Wang; Xiaofeng Fan; Yahua Zhang; Stephanie R Bennett; Ming-Zhi Zhang; Raymond C Harris
Journal:  JCI Insight       Date:  2022-02-22

Review 4.  Balkan nephropathy: evolution of our knowledge.

Authors:  Giorgos Bamias; John Boletis
Journal:  Am J Kidney Dis       Date:  2008-09       Impact factor: 8.860

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.